Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
33081
-
33082
Table 1_Systematic pharmacology-based strategy to investigate the mechanism of beta-sitosterol for the treatment of rheumarthritis.docx
Published 2024“…Compared to the control group, the mRNA expression of MMP9, HSP90AA1, SRC, EGFR, and ALB decreased (p< 0.01), while the apoptosis-related gene CASP3 increased in both the drug intervention (80 μmol/L β-sitosterol) and positive drug groups (80 μmol/L methotrexate).…”
-
33083
Data_Sheet_1_Causal relationship among obesity and body fat distribution and epilepsy subtypes.docx
Published 2022“…Furthermore, children with a higher BMI exhibit a higher risk of epilepsy (beta = 0.0148 P = 1.05 × 10<sup>−3</sup>). …”
-
33084
-
33085
-
33086
-
33087
-
33088
-
33089
-
33090
Table1_Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves’ Orbitopathy.DOCX
Published 2022“…Network meta-analysis suggested that the weekly intravenous GC regime (WR) [response: odds ratio (OR), 4.27; 95% creditable interval (CrI); 1.82 to 11.02; clinical activity score change (CASC): standard mean difference (SMD), −0.59; 95% CrI; −1.19 to −0.03) and monthly intravenous regime (MR) (response: OR, 6.32; 95% CrI; 1.25 to 34.96; CASC: SMD, −1.17; 95% CrI; −2.32 to −0.01) were superior to the oral GC (OGC) regime in response and CASC. …”
-
33091
-
33092
-
33093
-
33094
Data_Sheet_1_The pattern from the first three rounds of vaccination: declining vaccination rates.docx
Published 2023“…</p>Results<p>A total of 957 participants with chronic disease and 5,454 participants without chronic disease were included in this survey. …”
-
33095
Data_Sheet_1_Sleep, short-term memory, and mood states of volunteers with increasing altitude.pdf
Published 2022“…Digit span scores were decreased with increasing altitude (P < 0.001). A negative mood was more severe and a positive mood increasingly faded with rising elevation (P < 0.001). …”
-
33096
Data_Sheet_1_Plant Community Response to Forest Fuel Management in Patagonian Pine Plantations.PDF
Published 2020“…After 3 years, richness reached steppe values in most treatments (about 9 species/4 m<sup>2</sup>), whereas abundance did not (about 40% cover in the steppe and 5–25% in fuel treatments), and species composition similarity was low among treatments and steppe in all sites (Bray–Curtis index 0.1–0.6). Plant community composition was positively correlated with annual precipitation and initial residual biomass. …”
-
33097
Image1_The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain.jpeg
Published 2023“…The cucurbitacin D dose-dependently (0.025, 0.1, and 0.5 mg/kg) attenuated both allodynia types. …”
-
33098
Table1_The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain.docx
Published 2023“…The cucurbitacin D dose-dependently (0.025, 0.1, and 0.5 mg/kg) attenuated both allodynia types. …”
-
33099
Image 1_Lower hippocampal volumes at baseline are associated with higher volume loss in healthy elderly.png
Published 2025“…</p>Results<p>Hippocampal volumes decreased from baseline to follow-up [mean APC (SD): right −1.34% (0.94), left: −1.79% (1.00)]. …”
-
33100
Data_Sheet_1_Combined Use of Serum Uromodulin and eGFR to Estimate Mortality Risk.PDF
Published 2021“…In VIVIT, HRs were 3.12 (1.38–7.08), 2.38 (1.01–5.61), and 2.06 (0.81–5.22). …”